-transparent.png){kind=logo}
Tamoxifen was administered over a period of 4 weeks to 19 female Sprague-Dawley rats bearing 20 DMBA-induced mammary tumors. Consequently, 13 tumors (65.0 per cent) regressed and showed a reduction in their estradiol receptor (ER) and progesterone receptor (PgR) concentrations. In spite of subsequent treatment given to the rats bearing the regressed tumors, 6 new tumors occurred. The ER and PgR concentrations of these tumors were lower than those of the tumors before tamoxifen therapy, and histochemical study showed these tumors to be composed mostly of ER-negative cells. These results suggest that: (a) the hormone dependency of breast cancer is reduced by tamoxifen therapy; (b) breast cancers recurring during tamoxifen therapy show reduced hormone dependency.
K Inui, and
T Morimoto, and
K Komaki, and
H Sonoo, and
Y Monden
January 2005,
Zhonghua yi xue za zhi,
K Inui, and
T Morimoto, and
K Komaki, and
H Sonoo, and
Y Monden
August 1982,
Endocrinology,
K Inui, and
T Morimoto, and
K Komaki, and
H Sonoo, and
Y Monden
January 1966,
Archiv fur Geschwulstforschung,
K Inui, and
T Morimoto, and
K Komaki, and
H Sonoo, and
Y Monden
January 1984,
Eksperimental'naia onkologiia,
K Inui, and
T Morimoto, and
K Komaki, and
H Sonoo, and
Y Monden
June 1978,
European journal of cancer,
K Inui, and
T Morimoto, and
K Komaki, and
H Sonoo, and
Y Monden
February 1988,
Acta pathologica japonica,
K Inui, and
T Morimoto, and
K Komaki, and
H Sonoo, and
Y Monden
November 1974,
European journal of cancer,
K Inui, and
T Morimoto, and
K Komaki, and
H Sonoo, and
Y Monden
May 1970,
The Tohoku journal of experimental medicine,
K Inui, and
T Morimoto, and
K Komaki, and
H Sonoo, and
Y Monden
January 1981,
Journal of receptor research,
K Inui, and
T Morimoto, and
K Komaki, and
H Sonoo, and
Y Monden
March 1993,
The Journal of steroid biochemistry and molecular biology,
